A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

Clinical trial NCT01561911 · COMPLETED

Trial details

NCT number: NCT01561911
Sponsor: Cancer Research UK
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Neoplasms Lymphoma Non-Hodgkin B-Cell

Start date: 2007-07-01
Primary completion: 2014-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.